China Extracorporeal Life Support Registry

Recruiting now

Conditions studied: Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Distress Syndrome, Acute Respiratory Failure

In brief

Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.

Key facts

Study ID

NCT04158479

Run by

Beijing Anzhen Hospital

People needed

20000

Starts

2017-01-01

Expected to finish

2030-12-31

Last updated by the study team

2024-04-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients receiving ECMO for circulatory and/or respiratory support

You may not qualify if…

• Refusal of consent

Where it is running

• Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.